SCHEMBL1507930

SCHEMBL1507930

CCOP(=O)(O)C(OCC(C)C)(c1ccc(F)cc1)c1ccccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.40
CYP3A4 P08684 2/20 0.39
KCNE1 P15382 1/20 0.38
KCNQ1 P51787 1/20 0.38
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 2/20 0.35
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1507927 0.81 KCNN4 (0.37) KCNN4CYP3A4KCNE1KCNQ1KMT2A
SCHEMBL1508012 0.78 KCNN4 (0.47) KCNN4KCNE1KCNQ1ALDH1A1KMT2A
SCHEMBL1508117 0.76 ALDH1A1 (0.40) KCNN4ALDH1A1KMT2AMEN1LMNA
SCHEMBL1508149 0.73 KCNN4 (0.41) KCNN4KCNE1KCNQ1ALDH1A1KMT2A
SCHEMBL1508245 0.70 ALDH1A1 (0.42) KCNN4ALDH1A1KMT2AMEN1LMNA
SCHEMBL1507955 0.69 ALDH1A1 (0.42) KCNN4ALDH1A1KMT2AMEN1LMNA
SCHEMBL781360 0.67 KCNN4 (0.44) KCNN4KCNE1KCNQ1ALDH1A1KDM4E
SCHEMBL1508095 0.66 HDAC6 (0.40) ALDH1A1KMT2AMEN1KDM4E
SCHEMBL777579 0.64 KCNN4 (0.50) KCNN4KCNE1KCNQ1
SCHEMBL1508255 0.64 KMT2A (0.42) ALDH1A1KMT2AMEN1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1911740-A1 POTASSIUM CHANNEL MODULATORS NeuroSearch A/S (DK) 2008-04-16 EP claimed
US-20070161607-A1 Potassium channel modulators SANIONA A/S (DK) 2007-07-12 US claimed
US-20050009816-A1 Potassium channel modulators SANIONA A/S (DK) 2005-01-13 US claimed
EP-1465863-A1 POTASSIUM CHANNEL MODULATORS Poseidon Pharmaceuticals A/S (DK) 2004-10-13 EP claimed
WO-2003059873-A1 POTASSIUM CHANNEL MODULATORS POSEIDON PHARMACEUTICALS A/S (DK) 2003-07-24 WO claimed
EP-2292595-A1 Potassium channel modulators NeuroSearch AS (DK) 2011-03-09 EP disclosed
US-7429618-B2 Potassium channel modulators NEUROSEARCH A/S (DK) 2008-09-30 US disclosed
EP-1911740-A1 POTASSIUM CHANNEL MODULATORS NeuroSearch A/S (DK) 2008-04-16 EP disclosed
US-20070161607-A1 Potassium channel modulators SANIONA A/S (DK) 2007-07-12 US disclosed
US-7208527-B2 Potassium channel modulators POSEIDON PHARMACEUTICALS A/S (DK) 2007-04-24 US disclosed
US-20050009816-A1 Potassium channel modulators SANIONA A/S (DK) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009816-A1 Potassium channel modulators KCNC1, KCNQ1, KCNA1 KCNN4 48/4885CYP3A4 2918/4885KCNE1 29/4885
US-20070161607-A1 Potassium channel modulators KCNC1, KCNQ1, KCNA1 KCNN4 48/4885CYP3A4 2918/4885KCNE1 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.